These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 7910437

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
    Woerner MG, Alvir JM, Saltz BL, Lieberman JA, Kane JM.
    Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Not all that moves is tardive dyskinesia.
    Khot V, Wyatt RJ.
    Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.
    Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, Hawkins KA, Gueorguieva RV, Glazer WM.
    J Clin Psychiatry; 2010 Apr; 71(4):463-74. PubMed ID: 20156410
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population.
    Brar JS, Parepally H, Chalasani L, Gopalani A, Appel N, Chengappa KN.
    Ann Clin Psychiatry; 2008 Apr; 20(3):139-44. PubMed ID: 18633740
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [Abstract] [Full Text] [Related]

  • 14. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN, Shelton MD, Baker RW, Schooler NR, Baird J, Delaney J.
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tardive dyskinesia: who is at risk?
    van Os J, Fahy T, Jones P, Harvey I, Toone B, Murray R.
    Acta Psychiatr Scand; 1997 Sep; 96(3):206-16. PubMed ID: 9296552
    [Abstract] [Full Text] [Related]

  • 18. Changing epidemiology of tardive dyskinesia: an overview.
    Jeste DV, Wyatt RJ.
    Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344
    [Abstract] [Full Text] [Related]

  • 19. Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life.
    Sweet RA, Mulsant BH, Gupta B, Rifai AH, Pasternak RE, McEachran A, Zubenko GS.
    Arch Gen Psychiatry; 1995 Jun; 52(6):478-86. PubMed ID: 7771918
    [Abstract] [Full Text] [Related]

  • 20. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
    Szafrański T.
    Psychiatr Pol; 2014 Jun; 48(6):1155-65. PubMed ID: 25717485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.